South San Francisco, California, United StatesFounded 202032+ employeesPrivate
$122.2M raisedSeed· last: series unknown (Mar 2026)· 5 rounds
Backed by(20 investors)
Structure Fund · LeadFuture Ventures · LeadGlobal Health Investment Corporation · LeadHenry M. Jackson Foundation · LeadNFX · Lead+11 more
Centivax develops broad-spectrum vaccines and therapeutic antibodies targeting infectious diseases and venomous threats. The company advances a universal influenza vaccine, antibody-based antivenoms effective across multiple snake species, and broad-spectrum anti‑infective programs against drug-resistant bacteria.
